Luminai, an AI-native enterprise automation platform for healthcare operations, has raised $38 million in a Series B round led by Peak XV Partners, bringing total funding to $60 million. Define Ventures joined as a new investor, with General Catalyst and Y Combinator continuing their backing. The San Francisco-based company addresses healthcare's administrative burden, which accounts for significant industry costs through fragmented systems and manual processes. Luminai's platform applies healthcare-trained AI to interpret unstructured data and coordinate end-to-end workflows across access, revenue cycle and compliance functions. Founded by Kesava Kirupa Dinakaran, the company employs talent from Palantir, Cruise, Google and Epic. The funding will expand product capabilities, grow engineering and deployment teams, and support additional enterprise customers as health systems seek scalable operational modernisation solutions.

We originated new companies from scratch to address the world’s unmet needs.

NYC Corporation, a Tokyo-based investment firm focused on business succession and growth support for small and medium enterprises, has executed a minority investment in Luminai Corporation, a startup developing AI solutions and products for the manufacturing sector. Luminai provides AI implementation support from strategy development to system operation, and develops products that help manufacturing companies improve quality, cost and delivery through data-driven insights. The company also acquires businesses facing succession challenges and supports their transformation through technology and finance. The partnership will involve deal referrals, joint AI pilot projects using NYC's portfolio companies, back-office support for Luminai's acquired businesses, and co-investment opportunities. NYC aims to build a new ecosystem for small and medium enterprises by investing in promising startups and regional companies.